Tufts’ Peter Neumann and cost-effectiveness analysis – Better health through better measurement – Harlow On Healthcare
Health Blawg
DECEMBER 10, 2018
criminal enforcement vs. treatment and rehabilitation) we have a natural experiment that can yield data to be looked at in a cost-effectiveness analysis. As Peter observed, it is challenging to include the non-health costs and benefits in the analysis. Given the differences in state-by-state approaches to the opioid epidemic (e.g
60 
Let's personalize your content